No increase in serious hypoglycemia, hyperglycemia after switch from analogue to human insulin

Forty-six percent of U.S. adults have hypertension

Early detection of prediabetes may reduce risk for developing cardiovascular disease

Many of us remember hearing the TV show police message, “1-ADAM-12, a 211 is in progress downtown.”  1-Adam-12 was the squad car identifier for a ’67 Plymouth Belvedere driven on the streets of Los Angeles in the late 60’s. During the show’s heyday and beyond, most every guy named Adam …

When I was studying to become a CDE, the students in our class who did not have diabetes were given the assignment to live as though we did have insulin-requiring diabetes for a period of time. It was very helpful. At that time, we did not have continuous glucose monitors (CGM), but we did have insulin, vials and syringes (not sure about the pens but I don’t recall those), glucose monitors, and other supplies. We gave ourselves normal saline as if it were insulin, checked our glucose at least four times/day, carb counted, and everything else required to manage our "diabetes" daily. One incident that stands out to me was a friend faking having a hypoglycemia event while waiting for her food at a restaurant. It was quite an eye-opening period of time for all of us.

Adam Brown, diagnosed with diabetes in 2001, serves as Senior Editor and columnist at diaTribe.org and Head of Diabetes Technology & Connected Care at Close Concerns. Adam writes an acclaimed column for diaTribe, Adam’s Corner, which has brought actionable diabetes tips to over 1 million people since 2013. Adam writes and speaks extensively about diabetes and chronic disease, and, at age 29, is recognized as a leading expert in diabetes technology. Adam graduated summa cum laude from the Wharton School of the University of Pennsylvania in 2011 as a Joseph Wharton and Benjamin Franklin Scholar.

In this week's Homerun Slides, we begin taking a look at Adam Brown's presentation as he answers the question, "Can diabetes apps make our lives easier?"

Autoimmunity persists in many patients even many years after diagnosis: Studies in patients with long disease duration suggest that beta-cell function may persist long after diagnosis in a significant proportion of patients. There is also evidence suggesting the co-existence of some low level of regeneration with chronic autoimmunity, as islet autoimmunity may also persist or perhaps be reactivated years after diagnosis. Indeed, significant proportions (30–40%) of islet or pancreas transplant recipients express one or more autoantibodies when evaluated prior to transplantation. Moreover, persisting autoreactive T-cell responses detected prior to transplantation correlate with islet graft failure on follow-up.

In this Exclusive Interview transcript, Adam Brown talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about diabetes apps, technology, and keeping up with the latest innovations.

In this Exclusive Interview, Adam Brown talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about diabetes apps, technology, and keeping up with the latest innovations.